CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research

1.5. ANALYST TOOLS AND MODELS

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies

3.3. PORTERS FIVE FORCES ANALYSIS

3.3.1. Bargaining Power Of Suppliers
3.3.2. Bargaining Power Of Buyers
3.3.3. Threat Of New Entrants
3.3.4. Intensity Of Competitive Rivalry
3.3.5. Threat Of Substitutes

3.4. MARKET SHARE ANALYSIS, 2015
3.5. MARKET DYNAMICS
3.6. DRIVERS

3.6.1. Growing number of accredited clinical laboratories

3.6.1.1. Increasing mandates on the use of quality controls from regulatory and accreditation bodies
3.6.1.2. Increasing Adoption of Third-Party multi-analyte Quality Controls

3.6.2. Restraints

3.6.2.1. Stringent regulatory requirements for the approval and commercialization of IVD and their quality control Products
3.6.2.2. Inadequate reimbursement policies for IVD quality control

3.6.3. Opportunities

3.6.3.1. Developing economies offer lucarative growth opportunities

CHAPTER 4 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE

4.1. OVERVIEW
4.2. QUALITY CONTROLS

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Whole Blood-Based Controls

4.2.4.1 Market size and forecast

4.2.5. Serum/plasma-based Controls

4.2.5.1. Market size and forecast

4.2.6. Urine-based controls

4.2.6.1. Market size and forecast

4.2.7. Other source-based controls

4.2.7.1. Market size and forecast

4.3. DATA MANAGEMENT SOFTWARE

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. QUALITY ASSURANCE SERVICES

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

CHAPTER 5 IVD QUALITY CONTROL PRODUCTS MARKET, BY APPLICATION

5.1. OVERVIEW
5.2. CLINICAL CHEMISTRY

5.2.1. Market size and forecast

5.3. IMMUNOASSAY

5.3.1. Market size and forecast

5.4. HEMATOLOGY

5.4.1. Market size and forecast

5.5. MOLECULAR DIAGNOSTICS

5.5.1. Market size and forecast

5.6. COAGULATION/HEMOSTASIS

5.6.1. Market size and forecast

5.7. MICROBIOLOGY

5.7.1. Market size and forecast

CHAPTER 6 IVD QUALITY CONTROL PRODUCTS MARKET, BY MANUFACTURER TYPE

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. INSTRUMENT MANUFACTURER CONTROLS

6.2.1. Market size & forecast

6.3. INDEPENDENT MANUFACTURER CONTROLS

6.3.1. Market size & forecast
6.3.2. Third-party controls

6.3.2.1. Market Size & Forecast

6.3.3. Instrument-Specific Controls

6.3.3.1. Market Size & Forecast

CHAPTER 7 IVD QUALITY CONTROL PRODUCTS MARKET, BY END USER

7.1. OVERVIEW
7.2. CLINICAL LABORATORIES

7.2.1. Market size and forecast

7.3. HOSPITALS

7.3.1. Market size and forecast

7.4. RESEARCH AND ACADEMIC INSTITUTES

7.4.1. Market size and forecast

7.5. OTHERS

7.5.1. Market size and forecast

CHAPTER 8 IVD QUALITY CONTROL PRODUCTS MARKET, BY GEOGRAPHY

8.1. INTRODUCTION

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.4. U.S. market size and forecast
8.2.5. Canada market size and forecast
8.2.6. Mexico market size and forecast

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.4. Germany market size and forecast
8.3.5. France market size and forecast
8.3.6. UK: market size and forecast
8.3.7. Italy market size and forecast
8.3.8. Rest of Europe: market size and forecast

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.4. Japan market size and forecast
8.4.5. China market size and forecast
8.4.6. India market size and forecast
8.4.7. Rest of Asia-Pacific market size and forecast

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.4. Latin America market size and forecast
8.5.5. Middle East market size and forecast
8.5.6. Africa market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1. SERACARE LIFE SCIENCES, INC.

9.1.1. Company overview
9.1.2. Operating business segments
9.1.3. Business performance
9.1.4. Key strategic moves and developments

9.2. TECHNOPATH DISTRIBUTION LTD.

9.2.1. Company overview
9.2.2. Operating business segments
9.2.3. Business performance
9.2.4. Key strategic moves and developments

9.3. BIO-RAD LABORATORIES INC.

9.3.1. Company overview
9.3.2. Business operating segments
9.3.3. Business performance
9.3.4. Key strategic moves and developments

9.4. ABBOTT LABORATORIES

9.4.1. Company overview
9.4.2. Operating business segments
9.4.3. Business performance

9.5. DANAHER CORPORATION

9.5.1. Company overview
9.5.2. Operating business segments
9.5.3. Business performance
9.5.4. Key strategic moves and developments

9.6. HELENA LABORATORIES CORPORATION

9.6.1. Company overview
9.6.2. Operating business segments
9.6.3. Business performance

9.7. ORTHO-CLINICAL DIAGNOSTICS, INC.

9.7.1. Company overview
9.7.2. Operating business segments
9.7.3. Business performance
9.7.4. Key strategic moves and developments

9.8. RANDOX LABORATORIES LTD.

9.8.1. Company overview
9.8.2. Operating business segments
9.8.3. Business performance
9.8.4. Key strategic moves and developments

9.9. F. HOFFMANN-LA ROCHE LTD.

9.9.1. Company overview
9.9.2. Operating business segments
9.9.3. Business performance
9.9.4. Key strategic moves and developments

9.10. SUN DIAGNOSTICS, LLC

9.10.1. Company overview
9.10.2. Operating business segments
9.10.3. Sun Diagnostics, LLC.: business segments
9.10.4. Business performance